Swedish Orphan Biovitrum AB (publ) (LON:0MTD)
309.94
+0.80 (0.26%)
At close: Oct 17, 2025
LON:0MTD Revenue
Swedish Orphan Biovitrum AB had revenue of 6.18 billion SEK in the quarter ending June 30, 2025, with 13.47% growth. This brings the company's revenue in the last twelve months to 26.97 billion, up 13.75% year-over-year. In the year 2024, Swedish Orphan Biovitrum AB had annual revenue of 26.03 billion with 17.65% growth.
Revenue (ttm)
26.97B SEK
Revenue Growth
+13.75%
P/S Ratio
4.11
Revenue / Employee
14.93M SEK
Employees
1,806
Market Cap
8.52B GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 26.03B | 3.90B | 17.65% |
Dec 31, 2023 | 22.12B | 3.33B | 17.74% |
Dec 31, 2022 | 18.79B | 3.26B | 21.00% |
Dec 31, 2021 | 15.53B | 268.00M | 1.76% |
Dec 31, 2020 | 15.26B | 1.01B | 7.11% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Shell | 198.54B |
BP p.l.c. | 134.89B |
Unilever | 51.24B |
AstraZeneca | 41.24B |
HSBC Holdings | 41.03B |
Rio Tinto Group | 39.22B |
GSK plc | 31.63B |
BAE Systems | 27.41B |